Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 212,076 shares at $13.82 ($2.8M) on 2021-02-17, disclosed to the SEC on 2021-02-18.
Open-market sale of $2.8M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.30 | 78,201 | $1.0M | 36.9% |
| 2 | $13.30 | 78,201 | $1.0M | 36.9% |
| 3 | $13.82 | 11,174 | $154K | 5.5% |
| 4 | $13.82 | 11,174 | $154K | 5.5% |
| 5 | $12.85 | 16,663 | $214K | 7.6% |
| 6 | $12.85 | 16,663 |
| $214K |
| 7.6% |
| Total | $13.28 avg | 212,076 | $2.8M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |